Meijers, J.C.M.

patient hiv-infected patients level protein study coagulation factor infection hiv-infected fluenza thrombin signi signi ficantly apcsr marker thrombosis d-dimer hiv infection disease vaccination fi brinolysis von willebrand factor fluenza vaccination laboratory cell activation plasma parameter activation protein c thromb antibody generation result thrombin generation haemost inhibitor anticoagulant hemostatic subject infarction change fviii antiretroviral therapy venou ficantly therapy siemens healthcare diagnostics sample antiretroviral range ficant tract syndrome slotervaart hospital value ficiency venous thrombosis state tract infection blood regimen reference resistance department procoagulant amsterdam brinolysi 2009 h 1n tract infections difference fviii levels risk factors protein c resistance healthcare effect vaccine phase brinogen factor viii laboratory parameters